Skip to main content
logo
Mangoceuticals, Inc. (MGRX)
NASDAQ: MGRX · Real-Time Price · USD
0.2251
-0.0067 (-2.89%)
Oct 26, 2026, 10:01 AM EDT - Market open

Mangoceuticals Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Oct '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Market Capitalization
51166--
Market Cap Growth
-81.23%83.71%6.40%---
Enterprise Value
51165--
Last Close Price
0.230.742.424.15--

Price Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Oct '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PS Ratio
16.3424.9710.077.96--
PB Ratio
0.330.750.457.52--
P/TBV Ratio
-11.77-7.52--

EV Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Oct '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
EV/Sales Ratio
16.5024.1610.386.47--

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Oct '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Debt / Equity Ratio
0.020.020.020.170.57-2.35
Net Debt / Equity Ratio
0.00-0.080.01-0.79-0.54-1.00
Net Debt / EBITDA Ratio
0.000.07-0.020.080.17-
Net Debt / FCF Ratio
-0.010.20-0.030.090.24-0.24
Asset Turnover
0.020.030.080.710.02-
Quick Ratio
0.161.670.043.502.620.57
Current Ratio
0.181.740.053.962.670.57
Return on Equity (ROE)
-95.10%-141.66%-118.31%-1326.69%-669.02%-
Return on Assets (ROA)
-46.97%-69.91%-62.72%-494.04%-242.68%-
Return on Capital Employed (ROCE)
-103.00%-115.80%-59.10%-966.80%-268.20%419.10%

Yields

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Oct '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Earnings Yield
-487.63%-181.27%-140.45%-158.13%--
FCF Yield
-75.53%-51.37%-78.46%-120.17%--
Buyback Yield / Dilution
-208.91%-408.93%-84.23%-49.22%-34.98%-
SEC Filings: 10-K · 10-Q